These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26178738)

  • 41. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
    Davis T; Salahi A; Welsh JB; Bailey TS
    Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. More Consumer Diabetes Products Using Technology to Get--and Stay--Connected.
    Dubois W
    Diabetes Self Manag; 2016; 33(2):36-8, 40, 42. PubMed ID: 27086399
    [No Abstract]   [Full Text] [Related]  

  • 43. New modalities in the treatment of pregnancies complicated by diabetes: drugs and devices.
    Chitayat L; Jovanovic L; Hod M
    Semin Fetal Neonatal Med; 2009 Apr; 14(2):72-6. PubMed ID: 19097953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Artificial pancreas: where are we in 2020 ?].
    Radermecker RP
    Rev Med Suisse; 2020 Aug; 16(703):1494-1497. PubMed ID: 32852170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technological Advances in Management of Diabetes Mellitus.
    Ioachimescu AG
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):xiii-xiv. PubMed ID: 31980125
    [No Abstract]   [Full Text] [Related]  

  • 49. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin.
    Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086
    [No Abstract]   [Full Text] [Related]  

  • 51. Insulin pump therapy guidelines for China (July 2010).
    Mu Y; Yin S;
    J Diabetes; 2012 Jun; 4(2):127-39. PubMed ID: 22107806
    [No Abstract]   [Full Text] [Related]  

  • 52. The INCA system: a further step towards a telemedical artificial pancreas.
    Gómez EJ; Hernando Pérez ME; Vering T; Rigla Cros M; Bott O; García-Sáez G; Pretschner P; Brugués E; Schnell O; Patte C; Bergmann J; Dudde R; de Leiva A
    IEEE Trans Inf Technol Biomed; 2008 Jul; 12(4):470-9. PubMed ID: 18632327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating innovative tools into the management of type 2 diabetes to improve patient self-management.
    Kruger DF
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():17-20. PubMed ID: 19402256
    [No Abstract]   [Full Text] [Related]  

  • 54. IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial.
    Heinemann L; Hermanns N
    J Diabetes Sci Technol; 2015 Aug; 10(1):185-90. PubMed ID: 26251370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infusion sets 101.
    Neithercott T
    Diabetes Forecast; 2015; 68(2):64-6. PubMed ID: 25812188
    [No Abstract]   [Full Text] [Related]  

  • 56. Insulin delivery device technology 2012: where are we after 90 years?
    Fry A
    J Diabetes Sci Technol; 2012 Jul; 6(4):947-53. PubMed ID: 22920823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.
    Oron T; Farfel A; Muller I; Miller S; Atlas E; Nimri R; Phillip M
    Diabetes Technol Ther; 2014 Nov; 16(11):699-705. PubMed ID: 25211216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm.
    Messer LH; Berget C; Forlenza GP
    Diabetes Technol Ther; 2019 Aug; 21(8):462-469. PubMed ID: 31140878
    [No Abstract]   [Full Text] [Related]  

  • 59. Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.
    Nørgaard K; Shin J; Welsh JB; Gjessing H
    J Diabetes Sci Technol; 2015 Mar; 9(2):215-20. PubMed ID: 25591857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bringing the artificial pancreas home: telemedicine aspects.
    Lanzola G; Capozzi D; Serina N; Magni L; Bellazzi R
    J Diabetes Sci Technol; 2011 Nov; 5(6):1381-6. PubMed ID: 22226255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.